Combined analyses of leucocyte and prolactinoma DNA from 4 patients and that of 11 tumor DNA samples did not identify any additional tumor-specific PRLR variants, thereby indicating that these PRLR variants are germline and that somatic PRLR mutations are unlikely to be involved in the development of prolactinomas in humans (Fig. 1). Here, PRLR is linked to neoplasm.